At the time of writing, BeOne Medicines Ltd ADR [ONC] stock is trading at $305.74, up 3.81%. An important factor to consider is whether the stock is rising or falling in short-term value. The ONC shares have gain 3.43% over the last week, with a monthly amount glided 26.76%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
BeOne Medicines Ltd ADR [NASDAQ: ONC] stock has seen the most recent analyst activity on April 07, 2025, when RBC Capital Mkts initiated its Outperform rating and assigned the stock a price target of $312. Previously, BofA Securities upgraded its rating to Buy on March 03, 2025, and elevated its price target to $320. JMP Securities started tracking the stock assigning a Mkt Outperform rating and suggested a price target of $288 on September 18, 2024. Macquarie started tracking with a Outperform rating for this stock on September 12, 2023, and assigned it a price target of $259. In a note dated August 17, 2023, Jefferies initiated an Buy rating and provided a target price of $287 on this stock.
For the past year, the stock price of BeOne Medicines Ltd ADR fluctuated between $155.75 and $300.00. Currently, Wall Street analysts expect the stock to reach $303.5 within the next 12 months. BeOne Medicines Ltd ADR [NASDAQ: ONC] shares were valued at $305.74 at the most recent close of the market. An investor can expect a potential drop of -0.73% based on the average ONC price forecast.
Analyzing the ONC fundamentals
According to BeOne Medicines Ltd ADR [NASDAQ:ONC], the company’s sales were 4.18B for trailing twelve months, which represents an 48.64% jump. Gross Profit Margin for this corporation currently stands at 0.85% with Operating Profit Margin at -0.07%, Pretax Profit Margin comes in at -0.06%, and Net Profit Margin reading is -0.09%. To continue investigating profitability, this company’s Return on Assets is posted at -0.07, Equity is -0.12 and Total Capital is -0.08. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.28.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 300.50 points at the first support level, and at 295.25 for the second support level. However, for the 1st resistance point, the stock is sitting at 309.93, and for the 2nd resistance point, it is at 314.11.
Ratios To Look Out For
It is important to note that BeOne Medicines Ltd ADR [NASDAQ:ONC] has a current ratio of 1.96. On the other hand, the Quick Ratio is 1.71, and the Cash Ratio is 1.27. Considering the valuation of this stock, the price to sales ratio is 8.02, the price to book ratio is 9.43.
Transactions by insiders
Recent insider trading involved Wang Lai, Global Head of R&D, that happened on Jul 18 ’25 when 700.0 shares were sold. Officer, WANG HOLDINGS LLC completed a deal on Jul 18 ’25 to buy 5000.0 shares. Meanwhile, Chief Executive Officer OYLER JOHN sold 27802.0 shares on Jul 09 ’25.
